Subscribe To
Cingulate announces detailed trial results from phase 3 adult efficacy and safety trial of ctx-1301 (dexmethylphenidate) for adhd
CTx-1301 Demonstrated Clinically Meaningful Improvements in Permanent Product Measure of Performance (P...
September 11, 2023, 10:00 am
Chinook therapeutics to present updated data from zigakibart (bion-1301) phase 1/2 trial in patients with iga nephropathy (igan) at the 60th european renal association (era) congress
SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developmen...
June 12, 2023, 4:00 pm
Cingulate announces successful transfer of ctx-1301 (dexmethylphenidate) proprietary ptr™ manufacturing processes to societal cdmo
Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced C...
May 3, 2023, 10:45 am
Why is cingulate (cing) stock up 72% today?
Cingulate (NASDAQ: CING ) stock is on the rise Friday after releasing positive data concerning its ADHD treatment. The big news today is Cingulate's C...
February 24, 2023, 7:47 am
Cingulate initiates phase 3 study of lead asset ctx-1301, designed as a true entire active-day treatment for adhd
Trial Results Expected 1H 2023 Company to Host Investor and Business Development Meetings Adjacent to Upcoming J.P. Morgan Healthcare Conference in Sa...
January 4, 2023, 11:45 am
Lion copper and gold closes spin out of option on butte valley porphyry copper-gold property, nevada
Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) reported that it has closed the previously announced deal to spin out its option on the Butte Valle...
April 7, 2022, 7:46 am
Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm
Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm
Cingulate outlines plan for pivotal attention deficit/hyperactivity disorder studies
Cingulate Inc CING plans to initiate Phase 3 studies for CTx-1301 for Attention Deficit/Hyperactivit...
February 8, 2022, 12:20 pm
Lion copper and gold inks deal to spin out its butte valley property option in nevada
Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...
February 1, 2022, 11:38 am
Lion copper and gold inks deal to spin out its butte valley property option in nevada
Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...
February 1, 2022, 11:38 am
Lion copper and gold inks deal to spin out its butte valley property option in nevada
Lion Copper and Gold Corp (TSX-V:LEO, OTCQB:LCGMF) has announced an agreement to spin out its option on the Butte Valley porphyry copper-gold proper...
February 1, 2022, 11:38 am